[{"NetIncomeLoss_1_Q1_USD":10369000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":892000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":48522000.0,"AssetsCurrent_0_Q1_USD":720247000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":10980000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":35000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":4000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":10797000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":43500.0,"DebtInstrumentInterestRateDuringPeriod_1_Q1_pure":0.067,"ProceedsFromSaleOfShortTermInvestments_1_Q1_USD":145282000.0,"Depreciation_1_Q1_USD":2900000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-55664000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":172000.0,"PaymentsToAcquireShortTermInvestments_1_Q1_USD":186653000.0,"PaymentsToAcquireInvestments_1_Q1_USD":1220000.0,"InterestPaidNet_1_Q1_USD":1686000.0,"ConvertibleDebtNoncurrent_0_Q1_USD":317338000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":10697000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":11271000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":27063000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":30.86,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"DeferredIncomeTaxAssetsNet_0_Q1_USD":104467000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"InterestExpenseDebtExcludingAmortization_1_Q1_USD":1705000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1_Q1_USD":45.29,"ShareBasedCompensation_1_Q1_USD":10110000.0,"Assets_0_Q1_USD":1287549000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":558335000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":10035000.0,"CommonStockSharesIssued_0_Q1_shares":43957510.0,"IncomeTaxesPaidNet_1_Q1_USD":1000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":72888000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":22874000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":50239000.0,"GainLossOnSaleOfPropertyPlantEquipment_1_Q1_USD":11000.0,"PaymentForContingentConsiderationLiabilityOperatingActivities_1_Q1_USD":0.0,"CommonStockValue_0_Q1_USD":44000.0,"NumberOfReportableSegments_1_Q1_segment":1.0,"IncomeTaxExpenseBenefit_1_Q1_USD":2355000.0,"AccountsReceivableNetCurrent_0_Q1_USD":52583000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-157000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_1_Q1_USD":-3209000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-18027000.0,"InterestCostsCapitalized_1_Q1_USD":1042000.0,"EarningsPerShareBasic_1_Q1_USD":0.24,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":102232000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":46.76,"ResearchAndDevelopmentExpense_1_Q1_USD":15879000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":8059000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":45966000.0,"GoodwillPeriodIncreaseDecrease_1_Q1_USD":0.0,"DepreciationDepletionAndAmortization_1_Q1_USD":4851000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":10325000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"OperatingLeaseLiability_0_Q1_USD":75169000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-150000.0,"Liabilities_0_Q1_USD":636731000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":69666000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":66699000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":1967000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-1351000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":10223000.0,"IncreaseDecreaseInInventories_1_Q1_USD":-43000.0,"ConvertibleDebtCurrent_0_Q1_USD":151647000.0,"CostsAndExpenses_1_Q1_USD":99590000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":-1127000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_1_Q1_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-254000.0,"CommonStockSharesAuthorized_0_Q1_shares":250000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":119027000.0,"OperatingIncomeLoss_1_Q1_USD":19437000.0,"CostOfRevenue_1_Q1_USD":31349000.0,"IncrementalCommonSharesAttributableToConversionOfDebtSecurities_1_Q1_shares":152000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":43833000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":31697000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":12081000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":10110000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":10423000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_1_Q1_USD":71.11,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":12724000.0,"Goodwill_0_Q1_USD":99547000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":155000.0,"OtherOperatingActivitiesCashFlowStatement_1_Q1_USD":155000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-146000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":81217000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_1_Q1_shares":6616.0,"LiabilitiesCurrent_0_Q1_USD":232084000.0,"AccountsPayableCurrent_0_Q1_USD":9110000.0,"NonoperatingIncomeExpense_1_Q1_USD":-6713000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":144822000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":7033000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"OperatingLeasePayments_1_Q1_USD":4600000.0,"InterestReceivable_0_Q1_USD":800000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":317259.0,"AdditionalPaidInCapital_0_Q1_USD":894108000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0689,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":94554000.0,"InterestExpenseDebt_1_Q1_USD":6971000.0,"AssetRetirementObligation_0_Q1_USD":2000000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":10325000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":12995000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":66699000.0,"InterestExpense_1_Q1_USD":6971000.0,"AmortizationOfFinancingCosts_1_Q1_USD":651000.0,"ShortTermInvestments_0_Q1_USD":523364000.0,"EarningsPerShareDiluted_1_Q1_USD":0.23,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-462000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":226039000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1_Q1_shares":96265.0,"AmortizationOfDebtDiscountPremium_1_Q1_USD":5657000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":10110000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":1287549000.0,"SharePrice_0_Q1_USD":70.09,"OperatingLeaseCost_1_Q1_USD":2922000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":1746000.0,"PreferredStockValue_0_Q1_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":65.49,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"InvestmentIncomeInterest_1_Q1_USD":415000.0,"InventoryNet_0_Q1_USD":64606000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":34.03,"OperatingLeaseLiabilityCurrent_0_Q1_USD":5503000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":5900000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-33258000.0,"LeaseCost_1_Q1_USD":3400000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-243506000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_1_Q1_pure":0.85,"VariableLeaseCost_1_Q1_USD":478000.0,"TaxesPayableCurrent_0_Q1_USD":721000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":5858478.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":-1701000.0,"LongTermInvestments_0_Q1_USD":34971000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_1_Q1_USD":15933000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":558215000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":13073000.0,"StockholdersEquity_0_Q1_USD":650818000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":5288000.0,"CommonStockSharesOutstanding_0_Q1_shares":43957510.0,"StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_1_Q1_shares":0.0,"Ticker":"PCRX","CIK":"1396814","name":"PACIRA BIOSCIENCES, INC.","OfficialName":"Pacira BioSciences Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3316489486.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210504"}]